- Proteasome inhibitors in the treatment of multiple myeloma2021 | Faculty of Medicine in Hradec Králové
- Carfilzomib - the selective proteasome inhibitor, the further expectation for the patients with the multiple myeloma2016 | Faculty of Medicine in Hradec Králové
- In vitro and in vivo investigation of cardiotoxicity associated with anticancer proteasome inhibitors and their combination with anthracycline2019 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Antiproliferative and proapoptotic effects of proteasome inhibitors and their combination with histone deacetylase inhibitors on leukemia cells2009 | First Faculty of Medicine
- A UHPLC-UV-QTOF study on the stability of carfilzomib, a novel proteasome inhibitor2016 | Faculty of Pharmacy in Hradec Králové
- Proteasome inhibitor MG-132 enhances whole-body protein turnover in rat +12006 | Faculty of Medicine in Hradec Králové
- The Proteasome Inhibitor Bortezhomib (Velcade) in the Treatment of Relapsed/Refracotry Multiple Myeloma: The First Experience in the Czech Republic2005 | First Faculty of Medicine
- The Proteasome Inhibitor Bortezomib (Velcade) in he Treatment of Relapsed/Refractory Multiple Myeloma. The First Experience in the Czech Republic2005 | First Faculty of Medicine
- Bortezomib - the 1st proteasome inhibitor in clinical practise2004 | First Faculty of Medicine
- Bortezomib - the 1st proteasome inhibitor in clinical practisePublication without faculty affiliation
- Direct effects of proteasome inhibitor AdaAhx3L3VS on protein and amino acid metabolism in rat skeletal muscle2005 | First Faculty of Medicine
- Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-292011 | Faculty of Pharmacy in Hradec Králové
- Bortezomib - the first proteasome inhibitor in clinical practise2003 | First Faculty of Medicine
- Carfilzomib, a selective proteasome inhibitor - new possibility in multiple myeloma treatment2016 | Faculty of Medicine in Hradec Králové
- Effect of proteasome inhibitors MG132, ZL3VS and AdaAhx3L3VS on muscle protein metabolism in septic rats2004 | Faculty of Pharmacy in Hradec Králové
- The effect of new proteasome inhibitors, belactosin A and C, on protein metabolism in isolated rat skeletal muscle2009 | Central Library of Charles University
- The effect of new proteasome inhibitors, belactosin A and C, on protein metabolism in isolated rat skeletal muscle2009 | Faculty of Pharmacy in Hradec Králové, Central Library of Charles University
- The effect of new proteasome inhibitors, belactosin A and C, on protein metabolism in isolated rat skeletal muscle2009 | First Faculty of Medicine
- The protein catabolism in sepsis is influenced by proteasome inhibitorsPublication without faculty affiliation
- Proteasome inhibitors - New Option in the Treatment of Tumor Diseases2004 | First Faculty of Medicine
- Modulation of inflammatory response by proteasome inhibitor in septic micePublication without faculty affiliation
- Effects of proteasome inhibitors MG132, ZL3VS and AdaAhx3L3VS on protein metabolism in septic rats2004 | Central Library of Charles University, Faculty of Medicine in Hradec Králové
- The effect of proteasome inhibitor MLN273 on protein and amino acid metabolism in hyperhermia +1Publication without faculty affiliation
- Influence of proteasome inhibitor MG132 on the proteolysis in the rat skeletal musclePublication without faculty affiliation
- Proteasome inhibitor MG132 has different effect on protein synthesis in healthy and septic ratsPublication without faculty affiliation
- Proteasome inhibitor MG-132 enhances whole-body protein turnover in rat2006 | Faculty of Pharmacy in Hradec Králové, Central Library of Charles University
- The defense against the cell kiss of the death2007 | Central Library of Charles University, Faculty of Medicine in Hradec Králové
- The defense against the cell kiss of the death2007 | Faculty of Medicine in Hradec Králové